Coave Therapeutics
Coave Therapeutics is a genetic medicines developer founded in 2014.
6
Funding Rounds
$94.2m
Money raised
Overview
Coave Therapeutics is a genetic medicines developer founded in 2014.
- Website:
- Business model: B2B
- Headquarters: Paris
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Coave Therapeutics has raised a total of $94.19m in funding over 6 rounds.
Key Insights:
- Coave Therapeutics Series B round, July 2021: $38.9m
- Coave Therapeutics September 2018 Series B Funding Round: $25m
- Coave Therapeutics November 2017 Series B Funding Round: $21m
- Coave Therapeutics November 2016 Series A Funding Round: $4.4m
- Coave Therapeutics November 2016 Series A Funding Round: $4.4m
- Coave Therapeutics January 2015 Seed Funding Round: $490k
Coave Therapeutics Series B round, July 2021
$38.9m
Coave Therapeutics September 2018 Series B Funding Round
$25m
Coave Therapeutics November 2017 Series B Funding Round
$21m
Coave Therapeutics November 2016 Series A Funding Round
$4.4m
Coave Therapeutics November 2016 Series A Funding Round
$4.4m
Coave Therapeutics January 2015 Seed Funding Round
$490k
Industries
Coave Therapeutics is active in the following industries: